Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks posted sharp premarket gains and losses.
Stocks · News reference
DataMEDS AI Stock Surges Wednesday: What's Driving the Action?
DataMEDS AI is surging Wednesday as investors digest the acquisition of an AI cancer diagnostics lab and contract research businesses.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
DataMEDS AI Stock Soars 65% Pre-market: Here's What You Need to Know
DataMEDS AI shares jumped 8.02% in overnight session Tuesday after the company completed its $1.5 million Helomics acquisition.
Axe Compute Announces Sale Of Helomics Cancer Diagnostics Unit To DataMEDS AI For Common Shares And Share Equivalents; Share Count Not Disclosed
DataMeds AI Shares Halted On Circuit Breaker To The Upside, Stock Now Up 311.73%
Nasdaq Gains Over 100 Points; US Retail Sales Beat Estimates
U.S. stocks edged higher as strong retail sales lifted sentiment; utilities gained, energy fell, oil dropped, while European and Asian markets advanced.
DataMeds shares are trading higher after the company announced it acquired Helomics.